Allergen-induced in vitro expression of IL-18, SLAM and GATA-3 mRNA in PBMC during sublingual immunotherapy

Allergy: European Journal of Allergy and Clinical Immunology

Volumn 62, Issue 8, 2007, Pages 949-953

  Savolainen, J ^a,b   Nieminen, K ^b   Laaksonen, K ^b   Laiho, T ^b   Jacobsen, L ^c   Lahesmaa, R ^b   Terho, E O ^b   Valovirta, E ^d  

^a UNIVERSITY OF TURKU   (Finland)

^b UNIVERSITY OF TURKU   (Finland)

^c ALK ABELLÓ   (Denmark)

^d Turku Allergy Center   (Finland)

Author keywords

GATA 3; Interleukin 18; Pollen allergy; Signalling lymphocytic activation molecule; Sublingual immunotherapy

Indexed keywords

CD150 ANTIGEN; INTERLEUKIN 10; INTERLEUKIN 18; MESSENGER RNA; PLACEBO; POLLEN EXTRACT; TRANSCRIPTION FACTOR GATA 3; TRANSFORMING GROWTH FACTOR BETA;

ADOLESCENT; ALDER; ALLERGIC RHINITIS; ARTICLE; BIRCH; CELLULAR IMMUNITY; CHILD; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOWN REGULATION; FEMALE; HAZELNUT; HUMAN; HUMAN CELL; IMMUNOTHERAPY; INFLAMMATION; MALE; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; RANDOMIZED CONTROLLED TRIAL; REAL TIME POLYMERASE CHAIN REACTION; SKIN MANIFESTATION; TH1 CELL; TH2 CELL; UPREGULATION;

ADMINISTRATION, SUBLINGUAL; ADOLESCENT; ALLERGENS; ALNUS; ANTIGENS, CD; BETULA; CELLS, CULTURED; CHILD; CHILD, PRESCHOOL; CORYLUS; DESENSITIZATION, IMMUNOLOGIC; DOUBLE-BLIND METHOD; FEMALE; GATA3 TRANSCRIPTION FACTOR; GENE EXPRESSION; HUMANS; INTERLEUKIN-18; LEUKOCYTES, MONONUCLEAR; MALE; POLLEN; RECEPTORS, CELL SURFACE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RHINITIS, ALLERGIC, SEASONAL; RNA, MESSENGER;

EID: 34447130898     PISSN: 01054538     EISSN: 13989995     Source Type: Journal    
DOI: 10.1111/j.1398-9995.2007.01426.x     Document Type: Article

References (36)

1. Canonica GW, Passalacqua G. Noninjection routes for immunotherapy. J Allergy Clin Immunol 2003 3 : 191 193.
2. Bousquet J, Demoly P. Specific immunotherapy - an optimistic future. Allergy 2006 61 : 1155 1158.
3. Valovirta E, Jacobsen L, Ljorring C, Koivikko A, Savolainen J. Clinical efficacy and safety of sublingual immunotherapy with tree pollen extract in children. Allergy 2006 61 : 1177 1183.
4. Durham SR, Sun Ying, Varney VA, Jacobson MA, Sudderick RM, Mackay IS et al. Grass pollen immunotherapy inhibits allergen-induced infiltration of CD4+ T lymphocytes and eosinophils in the nasal mucosa and increases the number of cells expressing messenger RNA for interferon-gamma. J Allergy Clin Immunol 1996 97 : 1356 1365.
5. Wilson DR, Nouri-ARIA KT, Walker SM, Pajno GB, O'Brien F, Jacobson MR et al. Grass Pollen Immunotherapy: symptomatic improvement correlates with reductions in eosinophils and IL-5 mRNA expression in the nasal mucosa during the pollen season. J Allergy Clin Immunol 2001 107 : 971 976.
6. Jutel M, Akdis M, Budak F, Aebischer-Casaulta C, Wrzyszcz M, Blaser K et al. IL-10 and TGF-beta cooperate in the regulatory T cell response to mucosal allergens in normal immunity and specific immunotherapy. Eur J Immunol 2003 33 : 1205 1214.
7. Francis JN, Till SJ, Durham SR. Induction of IL-10+CD4+CD25+ T cells by grass pollen immunotherapy. J Allergy Clin Immunol 2003 111 : 1255 1261.
8. Savolainen J, Laaksonen K, Rantio-Lehtimäki A, Terho EO. Increased expression of allergen induced in vitro IL-10 and IL-18 mRNA in PBMC of allergic rhinitis patients after specific immunotherapy. Clin Exp Allergy 2004 34 : 413 419.
9. Savolainen J, Jacobsen L, Valovirta E. Sublingual immunotherapy in children modulates allergen-induced in vitro expression of cytokine mRNA in PBMC. Allergy 2006 61 : 1184 1190.
10. Okamura H, Tsutsi H, Komatsu T, Yutsudo M, Hakura A, Tanimoto T et al. Cloning of a new cytokine that induces IFN-gamma production by T cells. Nature 1995 6552 : 88 91.
11. Hofstra CL, Van Ark I, Hofman G, Kool M, Nijkamp FR, Van Oosterhout AJM. Prevention of Th2-like cell responses by coadministration of IL-12 and IL-18 is associated with inhibition of antigen-induced airway hyperresponsives, eosinophilia, and serum IgE levels. J Immunol 1998 161 : 5054 5060.
12. Yoshimoto T, Tsutsui H, Tominaga K, Hoshino K, Okamura H, Akira S et al. IL-18 although antiallergic when administered with IL-12, stimulates IL-4 and histamine release by basophils. Proc Natl Acad Sci U S A 1999 96 : 13962 13966.
13. Aversa G, Carballido J, Punnonen J, Chang C-CJ, Hauser T, Cocks BG et al. SLAM and its role in T cell activation and Th cell responses. Immunol Cell Biol 1997 75 : 202 205.
14. Cocks BG, Chang C-CJ, Carballido JM, Yssel H, de Vries JE, Aversa G. A novel receptor involved in T-cell activation. Nature 1995 376 : 260 263.
15. Hämäläinen H, Meissner S, Lahesmaa R. Signaling lymphocytic activation molecule (SLAM) is differentially expressed in human Th1 and Th2 cells. J Immunol Methods 2000 42 : 9 19.
16. Laaksonen K, Junikka M, Lahesmaa R, Terho EO, Savolainen J. In vitro allergen-induced mRNA expression of signaling lymphocytic activation molecule by PBMC of patients with allergic rhinitis is increased during specific pollen immunotherapy. J Allergy Clin Immunol 2003 112 : 1171 1177.
17. Zheng W, Flavell RA. The transcription factor GATA-3 is necessary and sufficient for Th2 cytokine gene expression in CD4 T cells. Cell 1997 89 : 587 596.
18. Zhang DH, Cohn L, Ray P, Bottomly K, Ray A. Transcription factor GATA-3 is differentially expressed in murine Th1 and Th2 cells and controls Th2-specific expression of the interleukin-5gene. J Biol Chem 1997 272 : 21597 21603.
19. Ylikoski E, Lund R, Kyläniemi M, Filen S, Kilpeläinen M, Savolainen J et al. IL-12 up-regulates T-bet independently of IFN-gamma in human CD4+ T cells. Eur J Immunol 2005 35 : 3297 3306.
20. Higashi N, Gesser B, Kawana S, Thestrup-Pedersen K. Expression of IL-18 mRNA and secretion of IL-18 are reduced in monocytes from patients with atopic dermatitis. J Allergy Clin Immunol 2001 108 : 607 614.
21. Ho L-P, Davis M, Denison A, Wood FT, Greening AP. Reduced interleukin-18 levels in Bal specimens from patients with asthma compared to patients with sarcoidosis and healthy control subjects. Chest 2002 121 : 1421 1426.
22. El-Mezzein RE, Matsumoto T, Nomiyama H, Miike T. Increased secretion of IL-18 in vitro by peripheral blood mononuclear cells of patients with bronchial asthma and atopic dermatitis. Clin Exp Immunol 2001 126 : 193 198.
23. Verhaeghe B, Gevaert P, Holtappels G, Lukat KF, Lange B, Van Cauwenberge P et al. Up-regulation of IL-18 in allergic rhinitis. Allergy 2002 57 : 825 830.
24. Hamid QA, Schotman E, Jacobson MR, Walker SM, Durham SR. Increases in IL-12 messenger RNA+ cells accompany inhibition of allergen induced late skin responses after successful grass pollen immunotherapy. J Allergy Clin Immunol 1997 99 : 254 260.
25. Varney VA, Hamid QA, Gaga M, Ying S, Jacobson M, Frew AJ et al. Influence of grass pollen immunotherapy on cellular infiltration and cytokine mRNA expression during allergen-induced late-phase cutaneous responses. J Clin Invest 1993 92 : 644 651.
26. Dehlink E, Eiwegger T, Gerstmayr M, Kampl E, Bohle B, Chen KW et al. Absence of systemic immunologic changes during dose build-up phase and early maintenance period in effective specific sublingual immunotherapy in children. Clin Exp Allergy 2006 36 : 32 39.
27. Ferrante P, Fusi ML, Sarasella M, Caputo D, Biasin M, Trabattoni D et al. Cytokine production and surface marker expression in acute and stable multiple sclerosis: Altered IL-12 production and augmented signalling lymphocytic activation molecule (SLAM)-expressing lymphocytes in acute multiple sclerosis. J Immunol 1998 160 : 1514 1521.
28. Isomäki P, Aversa G, Cocks BG, Luukkainen R, Saario R, Toivanen P et al. Increased expression of signalling lymphocytic activation molecule in patients with rheumatoid arthritis and its role in the regulation of cytokine production in rheumatoid synovium. J Immunol 1997 159 : 2986 2993.
29. Isomäki P, Aversa G, Chang C-CJ, Luukkainen R, Nikkari S, Toivanen P et al. Expression of soluble human signalling lymphocytic activation molecule in vivo. J Allergy Clin Immunol 1998 103 : 114 118.
30. Lima MT, Wilson D, Pitkin L, Roberts A, Nouri-Aria K, Jacobson M et al. Grass pollen sublingual immunotherapy for seasonal rhinoconjunctivitis: a randomized controlled trial. Clin Exp Allergy 2002 32 : 507 514.
31. Ciprandi G, Fenoglio D, Cirillo I, Vizzaccaro A, Ferrera A, Tosca MA et al. Induction of interleukin 10 by sublingual immunotherapy for house dust mites: a preliminary report. Ann Allergy Asthma Immunol 2005 95 : 38 44.
32. Ippoliti F, De Santis W, Volterrani A, Lenti L, Canitano N, Lucarelli S et al. Immunomodulation during sublingual therapy in allergic children. Pediatr Allergy Immunol 2003 14 : 216 221.
33. Bellinghausen I, Metz G, Enk AH, Christmann S, Knop J, Saloga J. Insect venom immunotherapy induces interleukin-10 production and a Th2-toTh1 shift, and changes surface marker expression in venom-allergic subjects. Eur J Immunol 1997 27 : 1131 1139.
34. Akdis CA, Blesken T, Akdis M, Wütrich B, Blaser K. Role of interleukin 10 in specific immunotherapy. J Clin Invest 1998 102 : 98 106.
35. Secrist H, Chelen CJ, Wen J, Marshall JD, Umetsu DT. Allergen immunotherapy decreases interleukin 4 production in CD4+ T cells from allergic individuals. J Exp Med 1993 178 : 2123 2130.
36. Jutel M, Pichler WJ, Skrbic D, Urwyler A, Dahinden C, Muller UR. Bee venom immunotherapy results in decrease of IL-4 and IL-5 and increase of IFN-gamma secretion in specific allergen-stimulated T cell cultures. J Immunol 1995 154 : 4187 4194.